Literature DB >> 32199461

Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis.

Jan Yperman1,2,3, Thijs Becker4, Dirk Valkenborg4, Veronica Popescu5,6, Niels Hellings7, Bart Van Wijmeersch5,6, Liesbet M Peeters4,7.   

Abstract

BACKGROUND: Evoked potentials (EPs) are a measure of the conductivity of the central nervous system. They are used to monitor disease progression of multiple sclerosis patients. Previous studies only extracted a few variables from the EPs, which are often further condensed into a single variable: the EP score. We perform a machine learning analysis of motor EP that uses the whole time series, instead of a few variables, to predict disability progression after two years. Obtaining realistic performance estimates of this task has been difficult because of small data set sizes. We recently extracted a dataset of EPs from the Rehabiliation & MS Center in Overpelt, Belgium. Our data set is large enough to obtain, for the first time, a performance estimate on an independent test set containing different patients.
METHODS: We extracted a large number of time series features from the motor EPs with the highly comparative time series analysis software package. Mutual information with the target and the Boruta method are used to find features which contain information not included in the features studied in the literature. We use random forests (RF) and logistic regression (LR) classifiers to predict disability progression after two years. Statistical significance of the performance increase when adding extra features is checked.
RESULTS: Including extra time series features in motor EPs leads to a statistically significant improvement compared to using only the known features, although the effect is limited in magnitude (ΔAUC = 0.02 for RF and ΔAUC = 0.05 for LR). RF with extra time series features obtains the best performance (AUC = 0.75±0.07 (mean and standard deviation)), which is good considering the limited number of biomarkers in the model. RF (a nonlinear classifier) outperforms LR (a linear classifier).
CONCLUSIONS: Using machine learning methods on EPs shows promising predictive performance. Using additional EP time series features beyond those already in use leads to a modest increase in performance. Larger datasets, preferably multi-center, are needed for further research. Given a large enough dataset, these models may be used to support clinicians in their decision making process regarding future treatment.

Entities:  

Keywords:  Disease prognosis; Evoked potentials; Feature extraction; Machine learning; Multiple sclerosis

Year:  2020        PMID: 32199461     DOI: 10.1186/s12883-020-01672-w

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  13 in total

1.  Machine learning and clinical neurophysiology.

Authors:  Julian Ray; Lokesh Wijesekera; Silvia Cirstea
Journal:  J Neurol       Date:  2022-07-30       Impact factor: 6.682

2.  Bioinformatics evaluation of a novel angiogenesis related genes-based signature for predicting prognosis and therapeutic efficacy in patients with gastric cancer.

Authors:  Ning Ma; Jie Li; Ling Lv; Chunhua Li; Kainan Li; Bin Wang
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

3.  Association of a Novel DOCK2 Mutation-Related Gene Signature With Immune in Hepatocellular Carcinoma.

Authors:  Yushen Huang; Wen Luo; Siyun Chen; Hongmei Su; Wuchang Zhu; Yuanyuan Wei; Yue Qiu; Yan Long; Yanxia Shi; Jinbin Wei
Journal:  Front Genet       Date:  2022-05-10       Impact factor: 4.772

4.  Machine Learning Reveals a Multipredictor Nomogram for Diagnosing the Alzheimer's Disease Based on Chemiluminescence Immunoassay for Total Tau in Plasma.

Authors:  Lingyu Zhang; Danhua Wang; Yibei Dai; Xuchu Wang; Ying Cao; Weiwei Liu; Zhihua Tao
Journal:  Front Aging Neurosci       Date:  2022-05-13       Impact factor: 5.702

Review 5.  Machine Learning Use for Prognostic Purposes in Multiple Sclerosis.

Authors:  Ruggiero Seccia; Silvia Romano; Marco Salvetti; Andrea Crisanti; Laura Palagi; Francesca Grassi
Journal:  Life (Basel)       Date:  2021-02-05

6.  Identification and Comprehensive Analysis of FREM2 Mutation as a Potential Prognostic Biomarker in Colorectal Cancer.

Authors:  Hanpeng Du; Haiyue Wang; Fandong Kong; Mingjian Wu; Wei Chen; Jin Lyu; Sitong Zhou; Ronghua Yang
Journal:  Front Mol Biosci       Date:  2022-02-18

7.  Machine Learning Revealed Ferroptosis Features and a Novel Ferroptosis-Based Classification for Diagnosis in Acute Myocardial Infarction.

Authors:  Dan Huang; Shiya Zheng; Zhuyuan Liu; Kongbo Zhu; Hong Zhi; Genshan Ma
Journal:  Front Genet       Date:  2022-01-25       Impact factor: 4.599

8.  Comparison of Machine Learning Methods Using Spectralis OCT for Diagnosis and Disability Progression Prognosis in Multiple Sclerosis.

Authors:  Alberto Montolío; José Cegoñino; Elena Garcia-Martin; Amaya Pérez Del Palomar
Journal:  Ann Biomed Eng       Date:  2022-02-26       Impact factor: 3.934

Review 9.  Towards Multimodal Machine Learning Prediction of Individual Cognitive Evolution in Multiple Sclerosis.

Authors:  Stijn Denissen; Oliver Y Chén; Johan De Mey; Maarten De Vos; Jeroen Van Schependom; Diana Maria Sima; Guy Nagels
Journal:  J Pers Med       Date:  2021-12-11

10.  Integrative Analyses of Genes Associated With Otologic Disorders in Turner Syndrome.

Authors:  Ruoyan Xue; Qi Tang; Yongli Zhang; Mengyao Xie; Chen Li; Shu Wang; Hua Yang
Journal:  Front Genet       Date:  2022-02-22       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.